MENU

Why these 4 ASX shares are ending the week with a bang

The S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) has climbed off its lows but is still down 0.1% to 6,051.7 points in afternoon trade.

Four shares that have not let that hold them back are listed below. Here’s why they are ending the week with a bang:

The Appen Ltd (ASX: APX) share price has pushed 3% higher to $11.60. This morning S&P Dow Jones Indices released the changes to its S&P/ASX indices that will be effective at the open of trading on June 18, 2018. These changes will see the artificial intelligence and machine learnings dataset provider’s shares added to the S&P/ASX 200 later this month. This could open up Appen to fund managers that have previously been unable to buy it due to trading restrictions.

The Bubs Australia Ltd (ASX: BUB) share price has climbed 5% to 84 cents after the goat milk infant formula company announced two positive developments. According to the release, the company has entered into a binding manufacturing agreement with Australia Deloraine Dairy and signed a merchant services agreement with Chinese e-commerce giant Alibaba. The manufacturing deal with Australia Deloraine Dairy allows Bubs to commence the application process for CFDA registration. If granted, the company will be able to sell its product in China.

The Nanosonics Ltd (ASX: NAN) share price has raced 5.5% higher to $3.06. At one stage the infection control specialist’s shares had risen to a 52-week high of $3.13. This has been quite a turnaround for Nanosonics. Just seven weeks ago its shares were as low as $2.26 and short interest had risen to high levels.

The Paragon Care Ltd (ASX: PGC) share price is out of its trading halt and up over 4% to 86 cents after announcing a major acquisition in New Zealand. Paragon Care has reached an agreement to acquire REM Systems for a net enterprise value of NZ$54.4 million. REM Systems is a specialised medical distribution company supplying acute care hospitals, day surgeries, allied health clinics, medical practices and veterinary clinics throughout New Zealand and Australia. The deal looks like a good one to me and is expected to be 10% accretive to earnings in FY 2019.

4 Stocks for Building Wealth After 50

Renowned investor Scott Phillips just released a brand-new report detailing his 4 favorite stocks to buy right now.

And I don’t know about you, but I always pay attention when some of the best investors in the world give me a stock tip.

This is your chance to get in at the very beginning of what could prove to be very special investments.

Click here to get started today!

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Nanosonics Limited. The Motley Fool Australia owns shares of Appen Ltd. The Motley Fool Australia has recommended Paragon Care Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The 5 mining stocks we’re recommending in 2019…

For decades, Australian mining companies have minted money for individual investors like you and me. But if you believe the pundits and talking heads on TV, those days are long gone. Finito! Behind us forever…

We say nothing could be further from the truth. To earn the really massive returns, you’ve got to fish where others aren’t fishing—and the mining sector could be primed for a resurgence. That’s why top Motley Fool analysts just revealed their exciting new research on 5 ASX miners they believe could help you profit in 2019 and beyond…

Including:

The best way we see to play the global zinc shortage… Our #1 favourite large-cap miner (hint: it’s not BHP)… one early-stage gold miner we think could hit the motherlode… Plus two more surprising companies you probably haven’t heard of yet!

For free access to our brand-new research, simply click here or the link below. But be warned, this research is available free for a limited time only, and we reserve the right to withdraw it at any time.

Click here for your FREE report!